Interleukin-1β promotes the expression of monocyte chemoattractant protein-1 in human aorta smooth muscle cells via multiple signaling pathways

Experimental and Molecular Medicine

Volumn 41, Issue 10, 2009, Pages 757-764

  Jun, Hee Lim ^a   Hee, Jung Um ^a   Park, Jong Wook ^a   Lee, In Kyu ^b   Taeg, Kyu Kwon ^a  

^a Keimyung University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Aorta; Atherosclerosis; CCL2 protein, human; Interleukin 1 ; Myocytes, smooth muscle; NF B; Protein kinase C; Type C phospholipase

Indexed keywords

I KAPPA B; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; 1 (6 ((3 METHOXYESTRA 1,3,5(10) TRIEN 17 YL)AMINO)HEXYL) 1H PYRROLE 2,5 DIONE; 1-(6-((3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL)-1H-PYRROLE-2,5-DIONE; 2 PYRROLIDONE DERIVATIVE; BRIDGED COMPOUND; CCL2 PROTEIN, HUMAN; ESTRANE DERIVATIVE; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOLIPASE; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; THIOKETONE; TRICYCLODECANE 9 YL XANTHOGENATE; TRICYCLODECANE-9-YL-XANTHOGENATE;

AORTA MEDIA; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; ACTIVE TRANSPORT; AORTA; ATHEROSCLEROSIS; BIOSYNTHESIS; CELL CULTURE; CELL NUCLEUS; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; AORTA; ATHEROSCLEROSIS; BRIDGED COMPOUNDS; CELL NUCLEUS; CELLS, CULTURED; CHEMOKINE CCL2; ESTRENES; GENISTEIN; HUMANS; INTERLEUKIN-1BETA; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PHOSPHOLIPASES; PROTEIN-TYROSINE KINASES; PYRROLIDINONES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; THIONES;

EID: 70350704801     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2009.41.10.082     Document Type: Article

References (25)

1. Baek WK, Park JW, Lim JH, Suh SI, Suh MH, Gabrielson E, Kwon TK. Molecular cloning and characterization of the human budding uninhibited by benomyl (BUB3) promoter. Gene 2002;295:117-123 (Pubitemid 35283823)
2. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894-897 (Pubitemid 28410911)
3. Chen CC, Chen JJ, Chou CY. Protein kinase C alpha but not p44/42 mitogen-activated protein kinase, p38, or c-Jun NH(2)-terminal kinase is required for intercellular adhesion molecule-1 expression mediated by interleukin-1beta: involvement of sequential activation of tyrosine kinase, nuclear factor-kappaB-inducing kinase, and IkappaB kinase 2. Mol Pharmacol 2000;58:1479-1489
4. Chen YM, Chiang WC, Lin SL, Wu KD, Tsai TJ, Hsieh BS. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition. J Pharmacol Exp Ther 2004;309:978-986
5. Delva E, Jennings JM, Calkins CC, Kottke MD, Faundez V, Kowalczyk AP. Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol Chem 2008;283:18303-18313
6. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-2147
7. Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Mol Endocrinol 2001;15: 1941-1952
8. Furukawa Y, Matsumori A, Ohashi N, Shioi T, Ono K, Harada A, Matsushima K, Sasayama S. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res 1999;84:306-314 (Pubitemid 29095571)
9. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008;8:837-848
10. Iseki A, Kambe F, Okumura K, Niwata S, Yamamoto R, Hayakawa T, Seo H. Pyrrolidine dithiocarbamate inhibits TNF-alpha-dependent activation of NF-kappaB by increasing intracellular copper level in human aortic smooth muscle cells. Biochem Biophys Res Commun 2000;276:88-92
11. Kawakami A, Aikawa M, Nitta N, Yoshida M, Libby P, Sacks FM. Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein-and protein kinase C alpha-mediated nuclear factor-kappaB activation. Arterioscler Thromb Vasc Biol 2007;27:219-225 (Pubitemid 46360402)
12. Lee YW, Hennig B, Toborek M. Redox-regulated mechanisms of IL-4-induced MCP1 expression in human vascular endothelial cells. Am J Physiol Heart Circ Physiol 2003; 284:185-192 (Pubitemid 36076285)
13. Lim SP, Garzino-Demo A. The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites. J Virol 2000;74:1632-1640 (Pubitemid 30434018)
14. Lusis AJ. Atherosclerosis. Nature 2000;407:233-241
15. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 1997;385:540-544
16. Martin T, Cardarelli PM, Parry GC, Felts KA, Cobb RR. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol 1997;27:1091-1097 (Pubitemid 27197210)
17. Mori E, Komori K, Yamaoka T, Tanii M, Kataoka C, Takeshita A, Usui M, Egashira K, Sugimachi K. Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits. Circulation 2002;105:2905-2910 (Pubitemid 34666106)
18. Pickett CA, Manning N, Akita Y, Gutierrez-Hartmann A. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells. Mol Endocrinol 2002;16:2840-2852 (Pubitemid 36020662)
19. Ruegg UT, Burgess GM. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci 1989;10:218-220
20. Sasayama S, Okada M, Matsumori A. Chemokines and cardiovascular diseases. Cardiovasc Res 2000;45:267-269
21. Terkeltaub R, Boisvert WA, Curtiss LK. Chemokines and atherosclerosis. Curr Opin Lipidol 1998;9:397-405
22. Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl O, Fox JG, Wang TC. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 2008;14: 408-419
23. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994; 153:2052-2063 (Pubitemid 2138450)
24. Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol 2003;49:285-296
25. Zhao Y, He D, Zhao J, Wang L, Leff AR, Spannhake EW, Georas S, Natarajan V. Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells. J Biol Chem 2007;282:10172-10179 (Pubitemid 47093444)